Physician profile
Sunil Dedhia
NPI 1932369543
$13,912.37
in general payments reported to CMS, 2019-2025
26 companies · $741 in 2025
The $741 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,379 · 2020: $857 · 2021: $3,479 · 2022: $5,198 · 2023: $791 · 2024: $468 · 2025: $741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,589 · Travel and Lodging: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,588.63 |
| Travel and Lodging | $411.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $7,440.39 | 2019-2023 | |
| Medwest Associates | $3,594.35 | 2019-2023 | |
| Stryker Corporation | $742.68 | 2019-2025 | Alphavent, Iconix, Procinch |
| Electronic Waveform Lab, INC. | $368.11 | 2019-2023 | |
| Lightbody Medical Technologies INC | $321.01 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $267.41 | 2019-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $230.20 | 2019-2025 | Na, Tfn-Advance |
| Smith+Nephew, INC. | $195.27 | 2019-2023 | Real Intelligence, Acticoat 4" X 4", Renasys Go V2 Home |
| Catalyst Orthoscience | $167.20 | 2021-2025 | |
| Bioventus LLC | $107.69 | 2021-2025 | Supartz Fx Sodium Hyaluronate |
| Pacira Therapeutics, INC. | $76.45 | 2019-2020 | |
| Orthofix Medical, INC. | $56.25 | 2019-2025 | Physio-Stim |
| Djo, LLC | $54.38 | 2022 | |
| Ermi LLC | $50.71 | 2019-2020 | |
| Organogenesis INC. | $31.37 | 2023 | Puraply |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heraeus Medical, LLC. | $30.21 | 2021-2022 | |
| Abbvie INC. | $26.78 | 2024 | |
| Ethicon US, LLC | $24.68 | 2021 | |
| Heron Therapeutics, INC. | $21.04 | 2024 | Zynrelef |
| Linvatec Corporation | $20.09 | 2025 | Linvatec Shoulder Arthroscopy, Biobrace 23mm |
| Fx Shoulder Solutions, INC | $16.87 | 2019 | |
| Assertio Therapeutics, INC. | $15.87 | 2019 | |
| Medtronic USA, INC. | $15.01 | 2019 | |
| Pfizer INC. | $14.64 | 2019 | |
| Fidia Pharma USA INC. | $12.71 | 2020 | |
| Sonex Health, INC. | $11.00 | 2021-2024 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Dedhia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.